InterMune, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

iCD Research
February 2, 2012
39 Pages - SKU: ICDR6792444
License type:
Table of Contents Search inside this report Related Reports
Synopsis

ICD Research's InterMune, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.

Summary

ICD Research's InterMune, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about InterMune, Inc..

ICD Research's InterMune, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
  • Examines and identifies key information and issues about InterMune, Inc. for business intelligence requirements.
  • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
  • Provides data on company financial performance and competitive benchmarking.
  • The profile also contains information on business operations, company history, major products and services, prospects, key employees, locations and subsidiaries.
Reasons To Buy
  • Quickly enhance your understanding of InterMune, Inc. .
  • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
  • Increase business/sales activities by understanding your competitors’ businesses better.
  • Recognize potential partnerships and suppliers.
Key Highlights

InterMune, Inc. (InterMune) is a biopharmaceutical company and is into development and marketing of therapies in areas of pulmonology and hepatology. The company focuses on developing a pipeline of pulmonology and hepatology products for treating idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. Its pulmonology product, pirfenidone is marketed as Esbriet in the EU and as Pirespa in Japan for the treatment of IPF. Its hepatology product portfolio includes HCV protease inhibitor compound ITMN-191. The company sold the global development and commercialization rights to this product to Roche. InterMune is headquartered in California, the US.


 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


Pharmaceuticals Company Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!